Stem Cell Research

Reprogrammed Human Cells Supply Tissue For Transplantation

Published in Gene Therapy Weekly, December 20th, 2001

Advanced Cell Technology, Inc., (ACT) announced publication of its research on human somatic cell nuclear transfer and parthenogenesis. The report provides the first proof that reprogrammed human cells can supply tissue for transplantation.

Human embryonic stem (ES) cells, and other cells derived from the inner cell mass of the preimplantation embryo are totipotent, that is, they are capable of forming any cell or tissue in the human body. While numerous human ES cell lines are now in existence, they are of little value in human transplantation, as they would be rejected by a patient as foreign. Human therapeutic cloning has the potential to solve this problem by...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2001-12-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry